Cellular and cytokine changes in the alveolar environment among immunocompromised patients during Pneumocystis jirovecii infection

Medical Mycology

Volumn 48, Issue 8, 2010, Pages 1075-1087

  Iriart, Xavier ^a,b   Witkowski, Benoit ^a   Courtais, Caroline ^a   Abbes, Sarah ^a   Tkaczuk, Jean ^a   Courtade, Monique ^a   Cassaing, Sophie ^a,b   Fillaux, Judith ^a,b   Blancher, Antoine ^a   Magnaval, Jean François ^a   Pipy, Bernard ^b   Berry, Antoine ^a,b  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

alveolar leukocytes; bronchoalveolar lavage; colonization; cytokines; immunosuppression; Pneumocystis jirovecii

Indexed keywords

DECTIN 1; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; FUNGAL COLONIZATION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; LUNG ALVEOLUS MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MYCOSIS; NONHUMAN; PNEUMOCYSTIS JIROVECI; PROTEIN EXPRESSION;

BRONCHOALVEOLAR LAVAGE FLUID; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNOCOMPROMISED HOST; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; PULMONARY ALVEOLI;

PNEUMOCYSTIS JIROVECII;

EID: 78449252751     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2010.484027     Document Type: Article

References (73)

1. Roblot F, Godet C, Le Moal G, et al . Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur J Clin Micro-biol Infect Dis 2002; 21: 523-531.
2. Sepkowitz KA. Opportunistic infections in patients with and patients without Acquired Immunodef ciency Syndrome. Clin Infect Dis 2002; 34: 1098-1107.
3. Beck JM, Harmsen AG. Lymphocytes in host defense against Pneumocystis carinii. Semin Respir Infect 1998; 13: 330-338.
4. Benf eld TL, Kharazmi A, Larsen CG, Lundgren JD. Neutrophil chemotactic activity in bronchoalveolar lavage f uid of patients with AIDS-associated Pneumocystis carinii pneumonia. Scand J Infect Dis 1997; 29: 367-371.
5. Limper AH, Hoyte JS, Standing JE. The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung. J Clin Invest 1997; 99: 2110-2117.
6. Wright TW, Johnston CJ, Harmsen AG, Finkelstein JN. Analysis of cytokine mRNA prof les in the lungs of Pneumocystis carinii-infected mice. Am J Respir Cell Mol Biol 1997; 17: 491-500.
7. Thullen TD, Ashbaugh AD, Daly KR, et al . New rat model of Pneumocystis pneumonia induced by anti-CD4(+) T-lymphocyte antibodies. Infect Immun 2003; 71: 6292-6297.
8. Masur H, Ognibene FP, Yarchoan R, et al . CD4 counts as predictors of opportunistic pneumonias in human immunodef ciency virus (HIV) infection. Ann Intern Med 1989; 111: 223-231.
9. Gigliotti F, Crow EL, Bhagwat SP, Wright TW. Sensitized CD8+ T cells fail to control organism burden but accelerate the onset of lung injury during Pneumocystis carinii pneumonia. Infect Immun 2006; 74: 6310-6316.
10. Wright TW, Gigliotti F, Finkelstein JN, et al. Immune-mediated inf ammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia. J Clin Invest 1999; 104: 1307-1317.
11. Meissner NN, Lund FE, Han S, Harmsen A. CD8 T cell-mediated lung damage in response to the extracellular pathogen pneumocystis is dependent on MHC class I expression by radiation-resistant lung cells. J Immunol 2005; 175: 8271-8279.
12. Martin WJ, 2nd, Pasula R. Role of alveolar macrophages in host defense against Pneumocystis carinii. Am J Respir Cell Mol Biol 2000; 23: 434-435.
13. Gordon SB, Read RC. Macrophage defences against respiratory tract infections. Br Med Bull 2002; 61: 45-61.
14. Thomas CF, Jr., Limper AH. Pneumocystis pneumonia. N Engl J Med 2004; 350: 2487-2498.
15. Qureshi MH, Harmsen AG, Garvy BA. IL-10 modulates host responses and lung damage induced by Pneumocystis carinii infection. J Immunol 2003; 170: 1002-1009.
16. Chen W, Havell EA, Harmsen AG. Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection. Infect Immun 1992; 60: 1279-1284.
17. Romani L, Puccetti P. Controlling pathogenic inf ammation to fungi. Expert Rev Anti Infect Ther 2007; 5: 1007-1017.
18. Fillaux J, Malvy S, Alvarez M, et al . Accuracy of a routine real-time PCR assay for the diagnosis of Pneumocystis jirovecii pneumonia. J Microbiol Methods 2008; 75: 258-261.
19. Rennard SI, Basset G, Lecossier D, et al . Estimation of volume of epithelial lining f uid recovered by lavage using urea as marker of dilution. J Appl Physiol 1986; 60: 532-538.
20. Larsen HH, Masur H, Kovacs JA, et al . Development and evaluation of a quantitative, touch-down, real-time PCR assay for diagnosing Pneumocystis carinii pneumonia. J Clin Microbiol 2002; 40: 490-494.
21. Dargaville PA, South M, Vervaart P, McDougall PN. Validity of markers of dilution in small volume lung lavage. Am J Respir Crit Care Med 1999; 160: 778-784.
22. Vestbo J, Nielsen TL, Junge J, Lundgren JD. Amount of Pneumocystis carinii and degree of acute lung inf ammation in HIV-associated P. carinii pneumonia. Chest 1993; 104: 109-113.
23. Limper AH, Standing JE, Hoyte JS. The role of alveolar macrophages in Pneumocystis carinii elimination from the lower respiratory tract. J Eukaryot Microbiol 1996; 43: 12S.
24. Fleury J, Escudier E, Pocholle MJ, Carre C, Bernaudin JF. Cell population obtained by bronchoalveolar lavage in Pneumocystis carinii pneumonitis. Acta Cytol 1985; 29: 721-726.
25. Fleury-Feith J, Van Nhieu JT, Picard C, Escudier E, Bernaudin JF. Bronchoalveolar lavage eosinophilia associated with Pneumocystis carinii pneumonitis in AIDS patients. Comparative study with non-AIDS patients. Chest 1989; 95 : 1198-1201.
26. Young JA, Stone JW, McGonigle RJ, Adu D, Michael J. Diagnosing Pneumocystis carinii pneumonia by cytological examination of bronchoalveolar lavage f uid: report of 15 cases. J Clin Pathol 1986; 39 : 945-949.
27. Lasbury ME, Durant PJ, Bartlett MS, Smith JW, Lee CH. Correlation of organism burden and alveolar macrophage counts during infection with Pneumocystis carinii and recovery. Clin Diagn Lab Immunol 2003; 10 : 293-302.
28. Lasbury ME, Durant PJ, Ray CA, et al . Suppression of alveolar macrophage apoptosis prolongs survival of rats and mice with Pneumocystis pneumonia. J Immunol 2006; 176 : 6443-6453.
29. Agostini C, Adami F, Poulter LW, et al . Role of bronchoalveolar lavage in predicting survival of patients with human immunodef ciency virus infection. Am J Respir Crit Care Med 1997; 156: 1501-1507.
30. Koziel H, Li X, Armstrong MY, Richards FF, Rose RM. Alveolar macrophages from human immunodef ciency virus-infected persons demonstrate impaired oxidative burst response to Pneumocystis carinii in vitro. Am J Respir Cell Mol Biol 2000; 23 : 452-459.
31. Lasbury ME, Lin P, Tschang D, Durant PJ, Lee CH. Effect of bronchoalveolar lavage f uid from Pneumocystis carinii -infected hosts on phagocytic activity of alveolar macrophages. Infect Immun 2004; 72: 2140-2147.
32. Kolls JK, Habetz S, Shean MK, et al . IFN-gamma and CD8+ T cells restore host defenses against Pneumocystis carinii in mice depleted of CD4+ T cells. J Immunol 1999; 162 : 2890-2894.
33. Liao CP, Lasbury ME, Wang SH, et al . Pneumocystis mediates over-expression of antizyme inhibitor resulting in increased polyamine levels and apoptosis in alveolar macrophages. J Biol Chem 2009; 284 : 8174-8184.
34. O ' Riordan DM, Standing JE, Limper AH. Pneumocystis carinii glycoprotein A binds macrophage mannose receptors. Infect Immun 1995; 63 : 779-784.
35. Steele C, Marrero L, Swain S, et al. Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 beta-glucan receptor. J Exp Med 2003; 198: 1677-1688.
36. Koziel H, Eichbaum Q, Kruskal BA, et al . Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor down-regulation. J Clin Invest 1998; 102 : 1332-1344.
37. Saijo S, Fujikado N, Furuta T, et al . Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat Immunol 2007; 8 : 39-46.
38. Jensen BN, Lisse IM, Gerstoft J, Borgeskov S, Skinhoj P. Cellular prof les in bronchoalveolar lavage f uid of HIV-infected patients with pulmonary symptoms: relation to diagnosis and prognosis. Aids 1991; 5 : 527-533.
39. Kagi MK, Fierz W, Grob PJ, Russi EW. High proportion of gamma-delta T cell receptor positive T cells in bronchoalveolar lavage and peripheral blood of HIV-infected patients with Pneumocystis carinii pneumonias. Respiration 1993; 60 : 170-177.
40. Siminski J, Kidd P, Phillips GD, Collins C, Raghu G. Reversed helper/ suppressor T-lymphocyte ratio in bronchoalveolar lavage f uid from patients with breast cancer and Pneumocystis carinii pneumonia. Am Rev Respir Dis 1991; 143 : 437-440.
41. Smith RL, el-Sadr WM, Lewis ML. Correlation of bronchoalveolar lavage cell populations with clinical severity of Pneumocystis carinii pneumonia. Chest 1988; 93: 60-64.
42. Hotz P, Loos U, Luderitz B. Lymphocyte subpopulations in bronchoalveolar lavage f uid in AIDS. Dtsch Med Wochenschr 1994; 119: 289-295.
43. Croix DA, Board K, Capuano S, 3rd, et al. Alterations in T lymphocyte prof les of bronchoalveolar lavage f uid from SIV- and Pneumocystis carinii -coinfected rhesus macaques. AIDS Res Hum Retroviruses 2002; 18 : 391-401.
44. Kumar SD, Krieger BP CD4 lymphocyte counts and mortality in AIDS patients requiring mechanical ventilator support due to Pneumocystis carinii pneumonia. Chest 1998; 113 : 430-433.
45. Phair J, Munoz A, Detels R, et al . The risk of Pneumocystis carinii pneumonia among men infected with human immunodef ciency virus type 1. Multicenter AIDS Cohort Study Group. N Engl J Med 1990; 322 : 161-165.
46. Harmsen AG, Stankiewicz M. Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice. J Exp Med 1990; 172 : 937-945.
47. Joseph SB, Miner KT, Croft M. Augmentation of naive, Th1 and Th2 effector CD4 responses by IL-6, IL-1 and TNF. Eur J Immunol 1998; 28: 277-289.
48. Rajagopalan-Levasseur P, Allaert A, Dridba M, et al . Response to Pneumocystis infection in an immunocompetent host. FEMS Immunol Med Microbiol 1998; 22 : 107-121.
49. Wright TW, Johnston CJ, Harmsen AG, Finkelstein JN. Chemokine gene expression during Pneumocystis carinii-driven pulmonary inf ammation. Infect Immun 1999; 67 : 3452-3460.
50. Perenboom RM, van Schijndel AC, Beckers P, et al . Cytokine prof les in bronchoalveolar lavage f uid and blood in HIV-seronegative patients with Pneumocystis carinii pneumonia. Eur J Clin Invest 1996; 26 : 159-166.
51. Perenboom RM, Sauerwein RW, Beckers P, et al . Cytokine prof les in bronchoalveolar lavage f uid and blood in HIV-seropositive patients with Pneumocystis carinii pneumonia. Eur J Clin Invest 1997; 27: 333-339.
52. Zhang J, Tachado SD, Patel N, et al . Negative regulatory role of mannose receptors on human alveolar macrophage proinf ammatory cytokine release in vitro. J Leukoc Biol 2005; 78 : 665-674.
53. Perenboom RM, Beckers P, Van Der Meer JW, et al. Pro-inf ammatory cytokines in lung and blood during steroid-induced Pneumocystis carinii pneumonia in rats. J Leukoc Biol 1996; 60: 710-715.
54. Ding K, Shibui A, Wang Y, et al . Impaired recognition by Toll-like receptor 4 is responsible for exacerbated murine Pneumocystis pneumonia. Microbes Infect 2005; 7: 195-203.
55. Ruan S, Tate C, Lee JJ, et al . Local delivery of the viral interleukin-10 gene suppresses tissue inf ammation in murine Pneumocystis carinii infection. Infect Immun 2002; 70 : 6107-6113.
56. Linke M, Ashbaugh A, Demland J, et al . Resolution of Pneumocystis murina infection following withdrawal of corticosteroid induced immunosuppression. Microb Pathog 2006; 40 : 15-22.
57. Allaert A, Jouault T, Rajagopalan-Levasseur P, et al . Detection of cytokine mRNA in the lung during the spontaneous Pneumocystis carinii pneumonia of the young rabbit. J Eukaryot Microbiol 1997; 44: 45S.
58. Allaert A, Rajagopalan-Levasseur P, Jouault T, Camus D, Dei-Cas E. Role of alveolar macrophages during the spontaneous Pneumocystis carinii pneumonia of rabbit at weaning. J Eukaryot Microbiol 1996; 43: 23S.
59. Israel-Biet D, Esvant H, Laval AM, Cadranel J. Impairment of beta chemokine and cytokine production in patients with HIV related Pneumocystis jerovici pneumonia. Thorax 2004; 59 : 247-251.
60. Chen W, Havell EA, Gigliotti F, Harmsen AG. Interleukin-6 production in a murine model of Pneumocystis carinii pneumonia: relation to resistance and inf ammatory response. Infect Immun 1993; 61: 97-102.
61. Pottratz ST, Reese S, Sheldon JL. Pneumocystis carinii induces interleukin 6 production by an alveolar epithelial cell line. Eur J Clin Invest 1998; 28 : 424-429.
62. Crestani B, Cornillet P, Dehoux M, et al . Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo. Regulation by alveolar macrophage secretory products. J Clin Invest 1994; 94: 731-740.
63. Limper AH, Offord KP, Smith TF, Martin WJ, 2nd. Pneumocystis carinii pneumonia. Differences in lung parasite number and inf am-mation in patients with and without AIDS. Am Rev Respir Dis 1989; 140: 1204-1209.
64. Agusti C, Rano A, Rovira M, et al . Inf ammatory response associated with pulmonary complications in non-HIV immunocompromised patients. Thorax 2004; 59 : 1081-1088.
65. Bettelli E, Carrier Y, Gao W, et al . Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441 : 235-238.
66. Mangan PR, Harrington LE, O'Quinn DB, et al . Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006; 441 : 231-234.
67. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGF-beta in the context of an inf ammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24: 179-189.
68. Reid DM, Gow NA, Brown GD. Pattern recognition: recent insights from Dectin-1. Curr Opin Immunol 2009; 21 : 30-37.
69. Rudner XL, Happel KI, Young EA, Shellito JE. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect Immun 2007; 75 : 3055-3061.
70. Hu T, Takamoto M, Hida S, Tagawa Y, Sugane K. IFN-gamma def -ciency worsen Pneumocystis pneumonia with Th17 development in nude mice. Immunol Lett 2009; 127 : 55-59.
71. Ray CA, Lasbury ME, Durant PJ, et al . Transforming growth factor-beta activation and signaling in the alveolar environment during Pneumocystis pneumonia. J Eukaryot Microbiol 2006; 53 (Suppl. 1): S127 - 129.
72. Angelici E, Spezzano M, Vaccari S, et al . Urokinase plasminogen activator and TGF-beta production in immunosuppressed patients with and without P. jiroveci infection. Microb Pathog 2006; 41: 1-9.
73. Morris A, Wei K, Afshar K, Huang L. Epidemiology and clinical significance of Pneumocystis colonization. J Infect Dis 2008; 197: 10-17. (Pubitemid 351263460)